共 70 条
[1]
Oktay K(2018)Planned oocyte cryopreservation for women seeking to preserve future reproductive potential: an Ethics Committee opinion Fertil Steril 110 1022-1028
[2]
Harvey BE(2018)Fertility preservation in patients with cancer: ASCO clinical practice guideline update J Clin Oncol 36 1994-2001
[3]
Partridge AH(2016)Successful oocyte cryopreservation in reproductive-aged cancer survivors Obstet Gynecol 127 474-480
[4]
Quinn GP(2017)Oncocontraception in cancer care Proc Am Soc Clin Oncol 35 e18018-vvi70
[5]
Reinecke J(2013)Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 24 vi160-196
[6]
Taylor HS(2011)Long-acting reversible contraception: implants and intrauterine devices. Practice Bulletin No. 121 Obstet Gynecol 118 184-927
[7]
Wallace WH(2015)Changes in use of long-acting reversible contraceptive methods among US women, 2009–2012 Obstet Gynecol 126 917-S63
[8]
Wang ET(2013)Cost as a barrier to long-acting reversible contraceptive (LARC) use in adolescents J Adolesc Health 52 S59-88
[9]
Loren AW(2018)Impact of the levonorgestrel-releasing intrauterine device on controlled ovarian stimulation outcomes Fertil Steril 110 83-27
[10]
Druckenmiller S(2017)The progestin-containing intrauterine device (IUD) during ovarian stimulation and oocyte retrieval: should it stay or should it go? Fertil Steril 108 e12-696